Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic statesbioRxiv · 2026-08-03A systematic review of the pharmacokinetics of classical serotonergic psychedelic compounds in healthy adult subjects.Journal of psychopharmacology (Oxford, England) · 2026-07-31Psilocybin's effect on human brain synaptic plasticity.Translational Psychiatry · 2026-07-14Psilocybe Poisoning: Pathophysiology, Classification and Treatment. A Clinical Case ReviewMexican Journal of Medical Research ICSA · 2026-07-04Mechanistic insights toward dissociating therapeutic from psychedelic effects: bridging the gap between psychedelic research and mental health careTranslational Psychiatry · 2026-06-23Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomised [18F]FDG-PET study.Unknown journal · 2026-05-30Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-27PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under PsilocybinScientific Data · 2026-05-201080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral PowerSLEEP · 2026-04-30SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-04-30356. Psilocybin Therapy is Associated With Decreases in Markers of Mitochondrial Stress and Inflammation in an Open-Label Clinical Trial of Parkinson’s DiseaseBiological Psychiatry · 2026-04-24Mapping cognitive-behavioral approach in psychedelic-assisted treatment: a systematic review across phases with classic and non-classic psychedelicsEuropean Archives of Psychiatry and Clinical Neuroscience · 2026-03-27Psilocybin and Ibogaine in Cocaine-Seeking: Extinction Enhancement Without Relapse PreventionAddiction Biology · 2026-02-28Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counselingTherapeutic Advances in Drug Safety · 2026-02-28Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-01-25Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-19The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measuresJournal of Psychopharmacology · 2025-12-31Acute and post-dosing effects of single-dose psilocybin for obsessive-compulsive disorder in a randomized, double-blind, placebo-controlled trial: an interpretative phenomenological analysisFrontiers in Psychiatry · 2025-12-09Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsNeuropharmacology · 2025-11-01Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes.Unknown journal · 2025-10-30Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trialsNeuropharmacology · 2025-10-16Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activationUNC Libraries · 2025-10-15Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24Emerging mechanisms of psilocybin-induced neuroplasticity.Unknown journal · 2025-09-14Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions.Unknown journal · 2025-08-14Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET StudyResearch Square · 2025-07-26Deconstructing Psychedelic Phenomenology: A Thematic Analysis of Discrete Phases of the Psychedelic ExperienceBrain and Behavior · 2025-06-30Behavioural and pharmacological evaluation of the psilocybin analogue baeocystin in Wistar ratsProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-06-30FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-03-31Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-01-31DETERMINATION OF TRYPTAMINE ALKALOIDS AND THEIR STABILITY IN PSYCHOTROPIC MUSHROOMSThe International Journal of Neuropsychopharmacology · 2025-01-31Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’Cureus · 2025-01-28A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Unknown journal · 2024-12-18The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists.Unknown journal · 2024-10-08Change in occupational burnout measures in emergency medical service workers after a psychedelic experience induced by a single self-administered dose of psilocybin mushroomsJournal of Psychedelic Studies · 2024-09-08Psilocybin administered following extinction sessions does not affect subsequent cocaine cue reinstatement in male and female rats and miceNeuroscience · 2024-09-02THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31Psilocybin, peyote, mescaline, and lysergic acid diethylamide (LSD) use in a nationally representative population by cancer history.Journal of Clinical Oncology · 2024-05-31Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushroomsPsychopharmacology · 2024-04-29Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.Unknown journal · 2024-02-15Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-01-31Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratingsFrontiers in Psychiatry · 2024-01-08Psilocybin-induced default mode network hypoconnectivity is blunted in alcohol-dependent ratsTranslational Psychiatry · 2023-12-13Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin UseJournal of Psychoactive Drugs · 2023-10-09DOES THE PHENOMENOLOGY OF THE PSILOCYBIN EXPERIENCE PREDICT LONG-TERM EFFECTS ON MOOD AND WELL-BEING IN HEALTHY VOLUNTEERS?IBRO Neuroscience Reports · 2023-09-30Knocking on the Doors of Perception: the role of psilocybin in substance use disorder treatmentUnknown journal · 2023-07-18Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in ratsFrontiers in Neuroscience · 2023-06-21Psilocybin intoxication did not affect daytime or sleep-related declarative memory consolidation in a small sample exploratory analysisEuropean Neuropsychopharmacology · 2023-06-16Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trialFrontiers in Psychiatry · 2023-04-24Indigenous-Amazonian Traditional Medicine's Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study.Unknown journal · 2023-01-09When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s.História Ciências Saúde-Manguinhos · 2023-01-05In Search of: A Federal Safe Harbor for State Legalization of PsilocybinUnknown journal · 2022-12-31Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2022-12-31Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.International Journal of Molecular Sciences · 2022-11-14Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-16P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applicationsToxicology Letters · 2022-08-31Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.Translational Psychiatry · 2022-08-01Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.Journal of Personalized Medicine · 2022-06-18Natural language signatures of psilocybin microdosing.Psychopharmacology · 2022-06-08Psylocybin and Psilocin as new tools to fight depression: an overview of the Pharmacodynamic and pharmacokinetic mechanismsRevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia · 2022-04-05Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.Frontiers in Pharmacology · 2022-03-08Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of Psychopharmacology · 2021-12-16P.0729 Highlights of psychedelic history and current research on psilocybin application for treatment of depression - a comprehensive literature reviewEuropean Neuropsychopharmacology · 2021-11-30Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.Journal of Psychopharmacology · 2021-06-29Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2021-04-29Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.Unknown journal · 2021-04-21The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionFrontiers in Pharmacology · 2020-12-02The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-02Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensisDrug Testing and Analysis · 2020-10-28Psychedelic science in post-COVID-19 psychiatryIrish Journal of Psychological Medicine · 2020-08-18A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor bindingEuropean Neuropsychopharmacology · 2020-03-03Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTubeHarm Reduction Journal · 2019-11-27Spectral signatures of serotonergic psychedelics and glutamatergic dissociativesNeuroImage · 2019-06-23Rapid-acting antidepressants.Unknown journal · 2019-04-23Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing-study on P300 and mismatch negativity in healthy volunteers.Psychopharmacology · 2018-01-04The Effects of Hallucinogens on Gene Expression.Unknown journal · 2017-12-31Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.Harm Reduction Journal · 2017-09-04Proposal of 5-methoxy-N-methyl-N-isopropyltryptamine consumption biomarkers through identification of in vivo metabolites from mice.Unknown journal · 2017-06-04PM502. Effect of psilocybin on EEG brain connectivity in healthy volunteers - preliminary reportThe International Journal of Neuropsychopharmacology · 2016-05-26PM506. Psilocybin Clinical Trial: Acute Effects and its relationship to the brain activity as measured by quantitative EEGThe International Journal of Neuropsychopharmacology · 2016-05-26Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain.Neuropharmacology · 2015-07-16Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.Human Brain Mapping · 2015-05-21Analysis of psilocin, bufotenine and LSD in hair.Unknown journal · 2014-12-22Synthesis, hydrolysis and stability of psilocin glucuronide.Unknown journal · 2014-01-14EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatmentEuropean Psychiatry · 2013-12-31Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS.Unknown journal · 2012-11-26A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability.Unknown journal · 2011-12-02P.6.057 Effects of 2A receptor challenge by psilocybin on cognitive performance and neuroendocrine measures in healthy humans: A serotonin model of psychosisEuropean Neuropsychopharmacology · 2003-09-30Occurrence of psilocybin and psilocin in Psilocybe pseudobullacea (Petch) Pegler from the Venezuelan Andes.Unknown journal · 1994-06-30Relationship of CNS tryptaminergic processes and the action of LSD-like hallucinogens.Unknown journal · 1986-01-31The inhibition of food intake in the dog by LDS, mescaline, psilocin, d-amphetamine and phenylisopropylamine derivatives.Unknown journal · 1979-05-31The identification of LSD-like hallucinogens using the chronic spinal dog.Unknown journal · 1978-02-28The effects of psilocybin on primary process content in language.Unknown journal · 1976-12-31The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.Unknown journal · 1969-12-30